Structure Therapeutics (GPCR): Will Repeat Dosing Confirm Its 3.3% Weight-Loss Signal?
Structure Therapeutics Inc. (NASDAQ:GPCR) reported September 8 results for ACCG-2671, an oral dual amylin and calcitonin receptor agonist.
Structure Therapeutics Inc. (GPCR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Siren L.L.C. Raymond Debbane | 872,967 | $27,297,678 | 0.65% | |
| 2. | Rhenman & Partners Asset Management Henrik Rhenman | 183,300 | $5,731,791 | +27% | 0.63% |
| 3. | Squarepoint Ops LLC Maxime Fortin (Cio) | 104,907 | $3,280,442 | -17% | 0% |
| 4. | Leucadia National Ian Cumming And Joseph Steinberg | 122,322 | $1,275,003 | +202% | 0.01% |
| 5. | Antipodes Partners Jacob Mitchell | 19,088 | $596,882 | -63% | 0.01% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,354,478 | $292,514,527 | 0.01% | |
| 2. | 1,264,946 | $39,554,862 | 0.02% | |
| 3. | 858,784 | $26,854,176 | 0.04% | |
| 4. | 800,000 | $25,016,000 | 0.81% | |
| 5. | 332,122 | $10,385,454 | 0% |
News See All
8 Hidden Multibagger Stocks to Buy Now
In this article, we will look at the 8 Hidden Multibagger Stocks to Buy Now.
10 Best Mid-Cap Stocks That Could Double Your Money
In this article, we will take a look at some of the best mid-cap stocks that are currently offering at least 100% upside potential to investors. On June 13, CNBC reported that U.S.
8 Oversold Stocks to Buy Right Now
In this article, we will discuss the 8 Oversold Stocks to Buy Right Now.
10 Best Biotech Stocks with Highest Upside Potential
In this article, we will take a look at some of the best biotech stocks that are currently offering attractive upside to investors. On April 16, reports from J.P.
Structure Therapeutics (GPCR) Gained from Favorable Clinical Data
Meridian Funds, managed by ArrowMark Partners, released its fourth-quarter 2025 investor letter for “Meridian Small Cap Growth Fund”. A copy of the letter can be downloaded here. U.S.
Structure Therapeutics Inc. (GPCR) Has Gained Over 130% in 3 Months. Here is Why
Structure Therapeutics Inc. (NASDAQ:GPCR) is among the 14 best booming stocks to buy right now.
14 Best Booming Stocks to Buy Right Now
This article looks at the 14 Best Booming Stocks to Buy Right Now.
7 Stocks on Jim Cramer’s Radar Recently
Jim Cramer, the host of Mad Money, on Tuesday talked about the opening days of earnings season and the market’s uneven behavior. “The market gets so angry over nothing.
H.C. Wainwright Upgrades Structure Therapeutics (GPCR) on Massive Arbitrage Opportunity for Oral GLP-1
Structure Therapeutics Inc. (NASDAQ:GPCR) is one of the best up and coming stocks to buy according to Wall Street. On December 19, H.C.
Hedge Fund Resource Center